AMANDA GLENN: Open Payments
NPI 1750710513 · LIMERICK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,138 in 40 payments from 19 companies in 2025. Trend: 2023 $1,262 · 2024 $936 · 2025 $1,138
Food & beverage: $1,138
| Company | Payments | Amount |
|---|---|---|
| Ceribell, Inc. | 1 | $144 |
| Amgen Inc. | 1 | $131 |
| Merz Pharmaceuticals, LLC | 3 | $97 |
| ACADIA Pharmaceuticals Inc | 4 | $90 |
| SK Life Science, Inc. | 4 | $89 |
| Eisai Inc. | 3 | $84 |
| PFIZER INC. | 3 | $84 |
| ABBVIE INC. | 3 | $74 |
| Teva Pharmaceuticals USA, Inc. | 4 | $66 |
| Lilly USA, LLC | 3 | $52 |
Products named: POCKET EEG DEVICE, REPATHA, Leqembi, INBRIJA, NUPLAZID, NURTEC ODT, AUSTEDO XR, QULIPTA.
Industry payments across PA — which companies pay providers there.
